- recruitingPhase I
A clinical trial to assess whether a self-amplifying ribonucleic acid (saRNA) vaccine against Rabies viruses is safe and induces immune responses
This study is testing a new rabies vaccine (RAB-Vac) for the first time in humans. We want to check if it's safe and how your immune system reacts. It will involve healthy adults aged 18-50 and won't test if the vaccine protects against rabies.
United Kingdom · England - ongoing, recruitingTherapeutic confirmatory (Phase III)
A two-centre open-label non-inferiority trial to assess the immunogenicity and safety of an intradermal and an intramuscular single-visit dosing regimen of purified chick-embryo cell-culture rabies vaccine in adults
This study is looking at different ways to give the rabies vaccine to adults. It compares a new, simpler way with the usual method to see if it works just as well at protecting people from rabies and if it's safe.
Belgium - ongoing, recruitingTherapeutic confirmatory (Phase III)
A randomized controlled trial to compare the immunogenicity and skin imprinting of intradermal and intramuscular rabies vaccination < RABISKIMM >
This study compares two ways of giving the rabies vaccine – into the skin or into the muscle. We want to see which method is better at training your body's immune system to fight off the rabies virus, especially looking at how the immune cells remember the vaccine.
Belgium